User profiles for Anna Bergamaschi

Anna Bergamaschi

Sr. Manager
Verified email at genomichealth.com
Cited by 2917

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer

A Bergamaschi, YH Kim, P Wang… - Genes …, 2006 - Wiley Online Library
Breast cancer is a leading cause of cancer‐death among women, where the clinicopathological
features of tumors are used to prognosticate and guide therapy. DNA copy number …

[HTML][HTML] Human TRIM gene expression in response to interferons

L Carthagena, A Bergamaschi, JM Luna, A David… - PloS one, 2009 - journals.plos.org
Background Tripartite motif (TRIM) proteins constitute a family of proteins that share a conserved
tripartite architecture. The recent discovery of the anti-HIV activity of TRIM5α in primate …

PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer

A Bosch, Z Li, A Bergamaschi, H Ellis, E Toska… - Science translational …, 2015 - science.org
Activating mutations of PIK3CA are the most frequent genomic alterations in estrogen
receptor (ER)–positive breast tumors, and selective phosphatidylinositol 3-kinase α (PI3Kα) …

[HTML][HTML] Regularized multivariate regression for identifying master predictors with application to integrative genomics study of breast cancer

J Peng, J Zhu, A Bergamaschi, W Han… - The annals of applied …, 2010 - ncbi.nlm.nih.gov
In this paper, we propose a new method remMap—REgularized Multivariate regression for
identifying MAster Predictors—for fitting multivariate response regression models under the …

[HTML][HTML] The MYTHEN detector for X-ray powder diffraction experiments at the Swiss Light Source

A Bergamaschi, A Cervellino, R Dinapoli… - Journal of synchrotron …, 2010 - scripts.iucr.org
The MYTHEN single-photon-counting silicon microstrip detector has been developed at the
Swiss Light Source for time-resolved powder diffraction experiments. An upgraded version of …

Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance

A Bergamaschi, BS Katzenellenbogen - Oncogene, 2012 - nature.com
Many estrogen receptor (ER)-positive breast cancers respond well initially to endocrine
therapies, but often develop resistance during treatment with selective ER modulators (SERMs) …

[HTML][HTML] Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA

…, E McCarthy, CK Ellison, A Bergamaschi… - Nature …, 2020 - nature.com
Pancreatic cancer is often detected late, when curative therapies are no longer possible.
Here, we present non-invasive detection of pancreatic ductal adenocarcinoma (PDAC) by 5-…

EIGER: Next generation single photon counting detector for X-ray applications

R Dinapoli, A Bergamaschi, B Henrich… - Nuclear Instruments and …, 2011 - Elsevier
EIGER is an advanced family of single photon counting hybrid pixel detectors, primarily
aimed at diffraction experiments at synchrotrons. Optimization of maximal functionality and …

Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer

…, D Juric, S Hazra, S Singh, P Kim, A Bergamaschi… - Science …, 2014 - science.org
Both abundant epidermal growth factor receptor (EGFR or ErbB1) and high activity of the
phosphatidylinositol 3-kinase (PI3K)–Akt pathway are common and therapeutically targeted in …

[HTML][HTML] A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation

…, Y Ning, Z Deng, CWT Zhao, A Bergamaschi… - Nature …, 2020 - nature.com
DNA 5-hydroxymethylcytosine (5hmC) modification is known to be associated with gene
transcription and frequently used as a mark to investigate dynamic DNA methylation conversion …